Table 1. Model parameter and distributions.
Parameter | Mean | Low | High | s.d. | Distribution | Alpha | Beta | Lambda | Source |
---|---|---|---|---|---|---|---|---|---|
Event probabilities | |||||||||
Probability of failure for hospital IV | 0.082 | 0.048 | 0.109 | 0.01525 | Beta | 26.46 | 296.22 | Hidalgo et al, 1999; Innes et al, 2003; Rapoport et al, 1999 | |
Probability of failure for early discharge | 0.175 | 0.152 | 0.208 | 0.014 | Beta | 128.73 | 606.88 | Innes et al, 2003; Sebban et al, 2008 | |
Probability of failure for outpatient IV | 0.111 | 0.047 | 0.25 | 0.05075 | Beta | 4.14 | 33.17 | Minotti et al, 1999; Rubenstein et al, 1993 | |
Probability of failure for outpatient oral | 0.189 | 0.095 | 0.208 | 0.02825 | Beta | 36.11 | 154.95 | Hidalgo et al, 1999; Malik et al, 1995; Minotti et al, 1999; Rubenstein et al, 1993 | |
Probability of readmission for early dischargea | 0.5 | 0.25 | 0.75 | 0.125 | Beta | 7.50 | 7.50 | Innes et al, 2003; Sebban et al, 2008 | |
Probability of readmission for outpatient IVa | ‘0.01 | 0 | 0.5 | Triangular | Rapoport et al, 1999; Rubenstein et al, 1993 | ||||
Probability of readmission for outpatient POa | 0.853 | 0.75 | 0.938 | 0.047 | Beta | 47.57 | 8.20 | Hidalgo et al, 1999; Malik et al, 1995; Rubenstein et al, 1993 | |
Rate of HCRI | 0.006 | 0.0045 | 0.0075 | 0.00075 | Normal | Kamboj and Sepkowitz, 2009 | |||
Relative risk of HCRI for outpatient IV | 0.2 | 0.15 | 0.25 | 0.025 | Normal | Simon et al, 2000 | |||
Relative risk of HCRI for outpatient oral | 0.1 | 0.075 | 0.125 | 0.0125 | Normal | Sewonou et al, 2002; Simon et al, 2000 | |||
Utilities | |||||||||
Utility for inpatient IV | 0.65 | 0.08 | 1 | 0.23 | Beta | 2.15 | 1.16 | U | |
Utility for early discharge | 0.72 | 0.16 | 1 | 0.21 | Beta | 2.57 | 1.00 | U | |
Utility for outpatient IV | 0.75 | 0.05 | 1 | 0.2375 | Beta | 1.74 | 0.58 | U | |
Utility for outpatient oral | 0.72 | 0 | 1 | 0.25 | Beta | 1.60 | 0.62 | U | |
Relative reduction (factor) for utility if failure | 0.8 | 0.6 | 1 | 0.1 | Normal | Assumed | |||
Relative reduction (factor) for utility if HCRIb | 0.5 | 0.375 | 0.625 | 0.0625 | Normal | Assumed | |||
Relative reduction (factor) for utility if readmission | 0.5 | 0.375 | 0.625 | 0.0625 | Normal | Brown et al, 2001 | |||
Costs | |||||||||
Costs per inpatient stay per day | 2000 | 1000 | 4000 | 750 | Gamma | 7.11 | 0.0036 | C | |
Costs of initial consultation | 460 | 230 | 920 | 172.5 | Gamma | 7.11 | 0.0155 | C | |
Costs for outpatient visit | 320 | 160 | 640 | 120 | Gamma | 7.11 | 0.0222 | C | |
Costs of home care nurse per visit | 90 | 45 | 180 | 33.75 | Gamma | 7.11 | 0.0790 | C | |
Costs of first-line IV antibiotics per day | 100 | 50 | 200 | 37.5 | Gamma | 7.11 | 0.0711 | C | |
Costs of second-line IV antibiotics per day | 260 | 130 | 520 | 97.5 | Gamma | 7.11 | 0.0274 | C | |
Costs of oral antibiotics per day | 5 | 2.50 | 10 | 1.875 | Gamma | 7.11 | 1.4222 | C | |
Relative increase in costs of antibiotics for HCRIb | 1.5 | 1.125 | 1.875 | 0.1875 | Normal | Assumed | |||
Time parameter | |||||||||
Duration of inpatient stay for hospital IV | 6 | 3 | 12 | 2.25 | Gamma | 7.11 | 1.1852 | Rapoport et al, 1999 | |
Duration of inpatient stay for early discharge | 2 | 1 | 4 | 0.75 | Gamma | 7.11 | 3.5556 | Innes et al, 2003; Rapoport et al, 1999; Sebban et al, 2008 | |
Duration of outpatient treatment for early discharge | 4 | 2 | 8 | 1.5 | Gamma | 7.11 | 1.7778 | Rapoport et al, 1999; Sebban et al, 2008 | |
Duration of outpatient treatment | 6 | 3 | 12 | 2.25 | Gamma | 7.11 | 1.1852 | Rapoport et al, 1999; Rubenstein et al, 1993; Sebban et al, 2008 | |
Prolongation of therapy related to complicationc | 6 | 3 | 12 | 2.25 | Gamma | 7.11 | 1.1852 | Assumed | |
Time to complicationc | 3 | 1.5 | 6 | 1.125 | Gamma | 7.11 | 2.3704 | Hidalgo et al, 1999; Innes et al, 2003; Malik et al, 1995; Minotti et al, 1999; Rapoport et al, 1999; Rubenstein et al, 1993; Sebban et al, 2008 | |
Time to complication for early discharge at homec | 1 | 0.5 | 2 | 0.375 | Gamma | 7.11 | 7.1111 | Assumed |
C: costs were obtained from local finance offices and the Department of Pharmacy at Princess Margaret Hospital in Toronto, Ontario/Canada.
U: utilities (visual analogue scale scores, converted into standard gamble utilities) were derived from 77 adult cancer patients at Princess Margaret Hospital in Toronto, Ontario/Canada.
Conditional on failure of therapy.
Healthcare-related infection.
Complication=failure, readmission, healthcare-related infection.
Note: the probability of readmission for outpatient IV was 0% based on two published RCTs; however, to apply a reasonable distribution to this variable ( → triangular), a peak estimate of 1% (0.01) was chosen.